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Clinical Efficacy by Intratumoral Injection of DNA Encoding Human 
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Plasmid DNA encoding human Interleukin-12 (IL-12)
was produced under GMP conditions and injected into
lesions of nine patients with malignant melanoma (stage
IV) previously treated with both, standard and non-stand-
ard therapies. The treatment was based on efficacy in pre-
clinical studies with melanoma in mice and gray horses.
The DNA was applied in cycles, three injections per cycle,
up to seven cycles. Three therapy arms comprised low (2
mg), medium (4 mg) and high (10 to 20 mg) amounts of
total DNA. The therapy was well tolerated. Three out of
nine patients experienced a clinical response, 2 SD and 1
CR. One patient receiving a low dose of DNA experienced
a long-lasting stabilization of the disease for more than
three years, while the other two responders received high
doses of DNA. All patients but one (P9) experienced a
transient response at the intratumoral injection site.
Immunohistochemical staining of responders showed
local reduction of angiogenesis and lymphocyte infiltra-
tions. All patients, in particular the responders (P3, P7,
and P8) exhibited an antigen-specific immune response
against MAGE-1 and MART-1. Biopsies of responders
showed some increase of IL-12, IP-10 and IFN-γ. (Hu.
Gene Ther. 16, 35 (2005)). Combinations of IL-12 DNA
with other therapies show significant increase of efficacy
in preclinical studies and will be discussed.
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